EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT)
Clemens KratochwilGerman Cancer Research Center and Department of Nuclear Medicine, Universitätsklinikum Heidelberg, Heidelberg, GermanyWolfgang P. FendlerDepartment of Nuclear Medicine, |Universitätsklinikum Essen, Essen, GermanyMatthias EiberKlinikum rechts der Isar, Technische Universität München, Munich, GermanyRichard P. BaumZentralklinik Bad Berka, Bad Berka, GermanyMurat Fani BozkurtDepartment of Nuclear Medicine, Hacettepe University, Ankara, TurkeyJohannes CzerninDepartment of Molecular and Medical Pharmacology, University of California Los Angeles, California, USARoberto C. Delgado BoltonDepartment of Diagnostic Imaging (Radiology) and Nuclear Medicine, San Pedro University Hospital and Centre for Biomedical Research of La Rioja (CIBIR), Logroño, La Rioja, SpainSamer EzziddinDepartment of Nuclear Medicine, Universitätsklinikum des Saarlandes, Homburg, GermanyFlavio ForrerDepartment of Radiology and Nuclear Medicine, Kantonsspital St. Gallen, St. Gallen, SwitzerlandRodney J. HicksPeter MacCallum Cancer Institute, Melbourne, AustraliaThomas A. HopeDepartment of Abdominal Imaging and Nuclear Medicine, University of California San Francisco, California, USALevent KabasakalDepartment of Nuclear Medicine, Istanbul University, Istanbul, TurkeyMark KonijnenbergDepartment of Nuclear Medicine, Erasmus Medical Center, Rotterdam, The NetherlandsKlaus KopkaGerman Cancer Research Center and Department of Nuclear Medicine, Universitätsklinikum Heidelberg, Heidelberg, GermanyMichael LaßmannDepartment of Nuclear Medicine, Universitätsklinikum Würzburg, Würzburg, GermanyFelix M. MottaghyDepartment of Nuclear Medicine, Universitätsklinikum Aachen, Aachen, GermanyWim J.G. OyenDepartment of Biomedical Sciences, Humanitas University, Milan, ItalyKambiz RahbarDepartment of Nuclear Medicine, Universitätsklinikum Münster, Münster, GermanyHeiko SchöderMolecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, USAIrene VirgoliniDepartment of Nuclear Medicine, Medical University Innsbruck, Innsbruck, AustriaHans-Jürgen WesterDepartment of Chemistry, Technische Universität München, Garching, GermanyLisa BodeiMolecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, USAStefano FantiDepartment of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, ItalyUwe HaberkornGerman Cancer Research Center and Department of Nuclear Medicine, Universitätsklinikum Heidelberg, Heidelberg, GermanyKen HerrmannDepartment of Nuclear Medicine, |Universitätsklinikum Essen, Essen, Germany. [email protected]
2019en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0